GRI Bio, Inc. (GRI)

GRI Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0	0	0	0	0.1	0
Gross Profit	0	0	0	0	0.1	0
Selling, General & Admin	8.25	8.16	2	4.07	1.18	1.27
Research & Development	4.05	3.23	0.24	5.19	3.71	1.88
Operating Expenses	12.29	11.39	2.24	9.26	4.89	3.15
Operating Income	-12.29	-11.39	-2.24	-9.26	-4.79	-3.15
Interest Expense / Income	0.92	2.08	0.65	0.02	0.03	0.2
Other Expense / Income	-0.44	-0.43	0.33	0.03	-	0.11
Pretax Income	-12.77	-13.04	-3.22	-9.3	-4.82	-3.46
Net Income	-12.77	-13.04	-3.22	-9.3	-4.82	-3.46
Shares Outstanding (Basic)	0	0	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0	0	0
Shares Change	2786.59%	257.81%	314.15%	45.12%	27.00%	121.47%
EPS (Basic)	208.91	-367.25	-324.35	-3876.64	-2921.13	-2675.43
EPS (Diluted)	208.91	-367.25	-324.35	-3876.64	-2921.13	-2675.43
Free Cash Flow	-9.09	-9	-1.09	-8.31	-3.71	-2.88
Free Cash Flow Per Share	-28.61	-253.43	-109.65	-3469.14	-2246.44	-2217.66
Gross Margin	-	-	-	-	100.00%	-
Operating Margin	-	-	-	-	-4788.00%	-
Profit Margin	-	-	-	-	-4822.00%	-
Free Cash Flow Margin	-	-	-	-	-3708.00%	-
EBITDA	-11.85	-10.95	-2.56	-9.21	-4.71	-3.25
EBITDA Margin	-	-	-	-	-4714.00%	-
Depreciation & Amortization	0.01	0	0	0.07	0.07	0.02
EBIT	-11.86	-10.96	-2.56	-9.29	-4.79	-3.27
EBIT Margin	-	-	-	-	-4788.00%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).